Hyperlipidemia and apolipoprotein E are associated with intraocular pressure of thyroid-associated ophthalmopathy in a Chinese population: a cross-sectional study

Hyperlipidemia and apolipoprotein E are associated with intraocular pressure of thyroid-associated ophthalmopathy in a Chinese population: a cross-sectional study

ObjectiveThis study aimed to explore the clinical characteristics of thyroid-associated ophthalmopathy (TAO) with hyperlipidemia and to identify the key lipid indicator.MethodsPatients with TAO were recruited to this study and divided into two groups based on the presence of hyperlipidemia. TAO pati...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yu Chen, Xin Qi, Jingya Wang, Huayang Xu, Yushi Sun, Ling Wang, Xingchen Zhou, Mingqian He, Jiarui Zhao, Jinbo Zhang, Hairong He, Hui Guo, Bingyin Shi, Yue Wang, Meng Zhang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-11-01
Series:	Frontiers in Endocrinology
Subjects:	thyroid-associated ophthalmopathy hyperlipidemia intraocular pressure apolipoprotein E Graves’ ophthalmopathy
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2024.1484343/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Practical Guidelines Management of Graves Ophthalmopathy
by: Imam Subekti, et al.
Published: (2020-02-01)

Practical Guidelines Management of Graves Ophthalmopathy
by: Imam Subekti, et al.
Published: (2020-02-01)

Retinal and Choroidal Alterations in Thyroid-Associated Ophthalmopathy: A Systematic Review
by: Alexandra Magdalena Ioana, et al.
Published: (2025-02-01)

Validation of Indonesian Graves’ Ophthalmopathy Quality of Life Questionnaire and Its Association with Clinical Activity and Severity of Graves’ Ophthalmopathy
by: Cecilia Anggraini, et al.
Published: (2024-10-01)

Emerging therapeutic approaches in graves’ ophthalmopathy: an update on pharmacological interventions
by: Lin Wang, et al.
Published: (2025-07-01)

Can chimeric antigen receptors – based therapy bring a gleam of hope for thyroid-associated ophthalmopathy and other autoimmune diseases?
by: Zhou Weiyi, et al.
Published: (2025-04-01)

Validation of Indonesian Graves’ Ophthalmopathy Quality of Life Questionnaire and Its Association with Clinical Activity and Severity of Graves’ Ophthalmopathy
by: Cecilia Anggraini, et al.
Published: (2025-01-01)

Negative association between serum calcium and glucocorticoid-induced hypertension in thyroid-associated ophthalmopathy patients treated with methylprednisolone
by: Ling Wang, et al.
Published: (2025-04-01)

Extraocular muscle index as a novel indicator of inflammatory condition in graves’ ophthalmopathy patients
by: Fangkun Wu, et al.
Published: (2025-05-01)

Rituximab in the treatment of Graves’ disease and endocrine ophthalmopathy. Opportunities and limitations
by: T. S. Panevin, et al.
Published: (2023-10-01)

Explore the Possibility of Early Clinical Diagnosis of Endocrine Ophthalmopathy Based on Eye Symptoms of Hyperthyroidism
by: V. G. Likhvantseva, et al.
Published: (2016-12-01)

Prevalence of Graves ophthalmopathy among patients with thyroid disease
by: Erwin D. Palisoc, MD, et al.
Published: (2010-06-01)

Causal association between non-thyroidal autoimmune diseases and Graves' ophthalmopathy: A mendelian randomization study
by: Lan Ma, et al.
Published: (2025-02-01)

New Method of Calculating the Excess Amount of Soft Tissues of the Orbit in Patients with Endocrine Ophthalmopathy when Planning Operations
by: D. V. Davydov, et al.
Published: (2019-12-01)

Optimal timing for cataract surgery in patients with thyroid-associated ophthalmopathy
by: Na Miao, et al.
Published: (2025-04-01)

Update on pathogenesis and immunology of Graves’ ophthalmopathy
by: Larysa Krajewska-Węglewicz, et al.
Published: (2018-12-01)

HUBUNGAN FAKTOR RISIKO TERHADAP KEJADIAN OPHTHALMOPATHY GRAVES
by: Y. Andressa Nugroho W., et al.
Published: (2019-10-01)

Evaluation of the patients with Grave’s ophthalmopathy after the corticosteroids treatment
by: Janićijević-Petrović Mirjana, et al.
Published: (2012-01-01)

Radioiodine Thyroid Ablation in Graves′ Hyperthyroidism: Merits and Pitfalls
by: J. Nwatsock, et al.
Published: (2012-01-01)

MINIMALLY INVASIVE METHODS OF SURGICAL TREATMENT OF ENDOCRINE OPHTHALMOPATHY
by: O. V. Levchenko, et al.
Published: (2017-07-01)

Clinical polymorphism of endocrine ophthalmopathy
by: V. G. Likhvantseva, et al.
Published: (2014-07-01)

Effects of high-dose glucocorticoids on gut microbiota in the treatment of Graves’ ophthalmopathy
by: Xinhuan Su, et al.
Published: (2025-06-01)

Muller-muscle recession for mild to moderate upper-eyelid retraction
by: Victor B. Lopez, MD, et al.
Published: (2005-03-01)

Machine learning unveils hypoxia-immune gene hub for clinical stratification of thyroid-associated ophthalmopathy
by: Lu Chen, et al.
Published: (2025-07-01)

Transorbital Endoscopic Medial Orbitotomy and Decompression of the Optic Nerve in Patients with Endocrine Ophthalmopathy Complicated by Optical Neuropathy
by: O. V. Levchenko, et al.
Published: (2020-10-01)

The Value of MRI and Radiomics for the Diagnostic Evaluation of Thyroid-Associated Ophthalmopathy
by: Weiyi Zhou, et al.
Published: (2025-02-01)

Surgical Management of Strabismus in Thyroid Ophthalmopathy
by: Vidhya Chandran, et al.
Published: (2020-01-01)

Application of lacrimal gland herniation in judging the activity of thyroid-associated ophthalmopathy and predicting the efficacy of glucocorticoids
by: LI Biyun, LIN Jiating, ZOU Li, FENG Qianqiu, ZHANG Wu, WANG Xiaohong, DENG Hongrong, WANG Manman, ZENG Longyi, LIN Shuo
Published: (2025-05-01)

Safety, pharmacokinetics, and potential benefits of TSH-receptor-specific monoclonal autoantibody K1-70TM in Japanese Graves’ disease patients: results of a phase 1 trial
by: Jaeduk Yoshimura Noh, et al.
Published: (2025-08-01)

Signatures of Six Autophagy‐Related Genes as Diagnostic Markers of Thyroid‐Associated Ophthalmopathy and Their Correlation With Immune Infiltration
by: Qintao Ma, et al.
Published: (2024-12-01)

Lamina cribrosa curvature depth and index as novel parameters in Graves’ ophthalmopathy
by: Abdullah Ergen, et al.
Published: (2025-07-01)

Teprotumumab and sensorineural hearing loss: a propensity score-matched retrospective cohort study
by: Maxim John Levy Barnett, et al.
Published: (2025-07-01)

Quality of Life Study in Chronic Diseases: More Needed Than Ever
by: Laurentius Aswin Pramono
Published: (2025-01-01)

Inactive Graves’ orbitopathy: to treat or not to treat?
by: O. G. Panteleeva, et al.
Published: (2023-03-01)

Comparative effectiveness of various orbital decompression techniques in treating thyroid-associated ophthalmopathy: a systematic review and meta-analysis
by: Wei Guo, et al.
Published: (2024-12-01)

Cerium oxide nanoparticles attenuates fibrosis and inflammation in thyroid-associated ophthalmopathy via JNK pathway
by: Bo-Wen Wang, et al.
Published: (2025-07-01)

SEARCH FOR TARGET TISSUE IN THE EYE ORBIT FOR AUTOIMMUNE AGGRESSION OF THYROID ANTIBODIES IN ENDOCRINE OPHTHALMOPATHY
by: V. G. Likhvantseva, et al.
Published: (2017-10-01)

Thyroid-Associated Ophthalmopathy in a Hypothyroid Patient
by: Dorotea Filipan, et al.
Published: (2024-01-01)

N6-methyladenosine modification of THBS1 induced by affluent WTAP promotes Graves’ ophthalmopathy progression through glycolysis to affect Th17/Treg balance
by: Lin-na Li, et al.
Published: (2025-12-01)

A Case Report on the Thyroid and Eye Connection: A Deep Dive into Evaluation and Treatment Strategies
by: Iqra Mushtaq, et al.
Published: (2025-06-01)